Lecture

Preclinical and Clinical Trials in SMA Gene Therapy

Description

This lecture covers preclinical and clinical trials in spinal muscular atrophy (SMA) gene therapy, discussing the demonstration of potency in mice, efficiency in patients, phase 1 trial results, further trials by Novartis, adverse effects, cellular targeting, and future perspectives in genome engineering and therapeutic strategies.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.